457 related articles for article (PubMed ID: 36015212)
1. Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology.
Huang J; Xiao K
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015212
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
Miele E; Spinelli GP; Miele E; Di Fabrizio E; Ferretti E; Tomao S; Gulino A
Int J Nanomedicine; 2012; 7():3637-57. PubMed ID: 22915840
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in siRNA delivery for cancer therapy using smart nanocarriers.
Zhang P; An K; Duan X; Xu H; Li F; Xu F
Drug Discov Today; 2018 Apr; 23(4):900-911. PubMed ID: 29373841
[TBL] [Abstract][Full Text] [Related]
4. Engineering siRNA therapeutics: challenges and strategies.
Ali Zaidi SS; Fatima F; Ali Zaidi SA; Zhou D; Deng W; Liu S
J Nanobiotechnology; 2023 Oct; 21(1):381. PubMed ID: 37848888
[TBL] [Abstract][Full Text] [Related]
5. Advances in siRNA delivery in cancer therapy.
Singh A; Trivedi P; Jain NK
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):274-283. PubMed ID: 28423924
[TBL] [Abstract][Full Text] [Related]
6. The landscape of nanoparticle-based siRNA delivery and therapeutic development.
Moazzam M; Zhang M; Hussain A; Yu X; Huang J; Huang Y
Mol Ther; 2024 Feb; 32(2):284-312. PubMed ID: 38204162
[TBL] [Abstract][Full Text] [Related]
7. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
[TBL] [Abstract][Full Text] [Related]
8. Chemical and structural modifications of RNAi therapeutics.
Ku SH; Jo SD; Lee YK; Kim K; Kim SH
Adv Drug Deliv Rev; 2016 Sep; 104():16-28. PubMed ID: 26549145
[TBL] [Abstract][Full Text] [Related]
9. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
10. Nucleic acid delivery: the missing pieces of the puzzle?
Nguyen J; Szoka FC
Acc Chem Res; 2012 Jul; 45(7):1153-62. PubMed ID: 22428908
[TBL] [Abstract][Full Text] [Related]
11. Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics.
Sristi ; Almalki WH; Karwasra R; Gupta G; Singh S; Sharma A; Sahebkar A; Kesharwani P
Prog Mol Biol Transl Sci; 2024; 204():219-248. PubMed ID: 38458739
[TBL] [Abstract][Full Text] [Related]
12. Recent advances of siRNA delivery by nanoparticles.
Yuan X; Naguib S; Wu Z
Expert Opin Drug Deliv; 2011 Apr; 8(4):521-36. PubMed ID: 21413903
[TBL] [Abstract][Full Text] [Related]
13. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
Hong CA; Nam YS
Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
[TBL] [Abstract][Full Text] [Related]
14. Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy.
Mishra DK; Balekar N; Mishra PK
Drug Deliv Transl Res; 2017 Apr; 7(2):346-358. PubMed ID: 28050890
[TBL] [Abstract][Full Text] [Related]
15. Advances in modification and delivery of nucleic acid drugs.
Wang J; Tan M; Wang Y; Liu X; Lin A
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):417-428. PubMed ID: 37643976
[TBL] [Abstract][Full Text] [Related]
16. RNAi-based therapeutics and tumor targeted delivery in cancer.
Kara G; Calin GA; Ozpolat B
Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment.
Xie X; Yue T; Gu W; Cheng W; He L; Ren W; Li F; Piao JG
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896243
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in nanoparticle-based siRNA delivery for cancer therapy.
Lee JM; Yoon TJ; Cho YS
Biomed Res Int; 2013; 2013():782041. PubMed ID: 23844368
[TBL] [Abstract][Full Text] [Related]
19. Chemistry and formulations for siRNA therapeutics.
Gallas A; Alexander C; Davies MC; Puri S; Allen S
Chem Soc Rev; 2013 Oct; 42(20):7983-97. PubMed ID: 23857524
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
